65,437 trials
Head and Neck Cancer
Primary: Progression-free Survival (PFS) (3-year Rate Reported) — 61.2; 58.9 percentage of participants — p=0.76
Renal Cell Carcinoma
Primary: Percentage of Participants With Disease Progression Per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) Via Independent Review Committee (IRC)…
Arthritis, Psoriatic
Primary: Percentage of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response at Week 14 — 21.8; 75.1 Percentage of Participants — p=<0.001
Chronic Lymphocytic Leukemia
Primary: Percentage of Participants With Complete Response (CR), as Determined by the Investigator Using International Workshop on Chronic Lymphocytic Leukemia National Cancer…
Anaesthesia
Primary: Mean Airway Pressures — 7; 6; 8; 8 cmH20
Major Depressive Disorder
Primary: The SERT Binding Potential (BP) --(Only the Treatment Group Was Assessed) — 0.34 a ratio of target region to background
Thrombosis, Venous
Primary: Percentage of Participants With Venous Thromboembolism (VTE) During Efficacy Period — 8.3; 2.2 percentage of participants
Pain
Primary: Postoperative Pain — 3.55; 3.11 units on a visual analog scale
Healthy
Primary: Area Under the Concentration Versus Time Curve (AUC) (0-168) Profile of Levonorgestrel (LNG) — 157; 118; 153; 137 ng*hr/mL
Nicotine Dependence · Cigarette Smoking · Insomnia
Primary: Smoking Abstinence — 1; 2; 1; 0 participants
HIV Infection
Primary: Number of Participants With Serum Creatinine Event of Grade 1 or Higher — 1 Participants
Amyotrophic Lateral Sclerosis (ALS)
Primary: Change From Baseline in Revised ALS Functional Rating Scale (ALSFRS-R) Score in Full Analysis Set (FAS) Population at 24 Weeks — -6.52; -6 units on a scale
Postoperative Pain · Paracervical Block · Laparoscopic Gynecologic Surgery
Primary: Number of Participants With Hospital Admission for Postoperative Pain Control — 23; 17; 10; 11 Participants
Bipolar I Depression
Primary: Change in the Children's Depression Rating Scale, Revised (CDRS-R) Total Score as Compared to Placebo From Double-Blind Baseline to Week 6 (Day 43) Baseline — 59.2…
Chronic Otitis Media · Anesthesia
Primary: Onset of Neuromuscular Blocking Agents(NMBAs) — 212.8; 230.1; 399.3 Second